<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">329738</article-id><article-id pub-id-type="doi">10.18565/aig.2017.6.176-82</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">MYCOPLASMA HOMINIS AS AN ETIOLOGICAL AGENT OF TUBO-OVARIAN ABSCESS AND PYOSALPINX: MYTH OR REALITY?</article-title><trans-title-group xml:lang="ru"><trans-title>MYCOPLASMA HOMINIS КАК ЭТИОЛОГИЧЕСКИЙ АГЕНТ ТУБООВАРИАЛЬНОГО АБСЦЕССА И ПИОСАЛЬПИНКСА. МИФ ИЛИ РЕАЛЬНОСТЬ?</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Guschin</surname><given-names>Alexander Evgen'evich</given-names></name><name xml:lang="ru"><surname>Гущин</surname><given-names>Александр Евгеньевич</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, Head of the Laboratory for Molecular Diagnostics of Reproductive Tract Infections</p></bio><bio xml:lang="ru"><p>к.б.н., руководитель лаборатории молекулярной диагностики и эпидемиологии инфекций органов репродукции</p></bio><email>aguschin1965@pcr.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rumyantseva</surname><given-names>Tatiana Andreevna</given-names></name><name xml:lang="ru"><surname>Румянцева</surname><given-names>Татьяна Андреевна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, Gynecologist, Research officer, Clinical Diagnostoc Center</p></bio><bio xml:lang="ru"><p>научный сотрудник лаборатории молекулярной диагностики и эпидемиологии инфекций органов репродукции; врач акушер-гинеколог Научно-консультативного клинико-диагностического центра</p></bio><email>Ivanovatatiana86@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Khayrullina</surname><given-names>Guzel Anvarovna</given-names></name><name xml:lang="ru"><surname>Хайруллина</surname><given-names>Гузель Анваровна</given-names></name></name-alternatives><bio xml:lang="en"><p>PhD, Research officer, Laboratory for Molecular Diagnostics of Reproductive Tract Infections</p></bio><bio xml:lang="ru"><p>к.б.н., научный сотрудник лаборатории молекулярной диагностики и эпидемиологии инфекций органов репродукции</p></bio><email>guzel.khairullina@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Makhova</surname><given-names>Tamara Igorevna</given-names></name><name xml:lang="ru"><surname>Махова</surname><given-names>Тамара Игоревна</given-names></name></name-alternatives><bio xml:lang="en"><p>Junior researcher, Laboratory for Molecular Diagnostics of Reproductive Tract Infections</p></bio><bio xml:lang="ru"><p>м.н.с. лаборатории молекулярной диагностики и эпидемиологии инфекций органов репродукции</p></bio><email>tamara.dolgova89@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Dukhin</surname><given-names>Armen Olegovich</given-names></name><name xml:lang="ru"><surname>Духин</surname><given-names>Армен Олегович</given-names></name></name-alternatives><bio xml:lang="en"><p>MD, PhD, Professor</p></bio><bio xml:lang="ru"><p>д. м. н., профессор кафедры акушерства и гинекологии с курсом перинатологии медицинского факультета</p></bio><email>aodukhin@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Welfare</institution></aff><aff><institution xml:lang="ru">ФБУН Центральный научно-исследовательский институт эпидемиологии Роспотребнадзора</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Peoples' Friendship University of Russia, Ministry of Education and Science</institution></aff><aff><institution xml:lang="ru">ФГАОУВО Российский университет дружбы народов Минобрнауки России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2017</year></pub-date><issue>6</issue><issue-title xml:lang="en">NO6 (2017)</issue-title><issue-title xml:lang="ru">№6 (2017)</issue-title><fpage>176</fpage><lpage>182</lpage><history><date date-type="received" iso-8601-date="2023-04-14"><day>14</day><month>04</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, ООО «Бионика Медиа»</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/329738">https://journals.eco-vector.com/0300-9092/article/view/329738</self-uri><abstract xml:lang="en"><p>Background. Despite the fact that M. hominis is commonly assigned to opportunistic microorganisms, there are many reports of clinical cases with the involvement of M. hominis as the only microorganism in the development of severe inflammatory processes in the lung, intervertebral discs, kidney, liver, heart, and brain. The role of M. hominis in the development of pelvic inflammatory diseases (PID) remains unexplored. Clinical case reports. The paper gives data on two patients admitted to hospital to be treated for tubo-ovarian abscess and pyosalpinx. The patients underwent a comprehensive examination, as well as laparoscopy, during which intraoperative samples were obtained and investigated by PCR to detect DNA of a broad spectrum of microorganisms. The material obtained from the two patients with PID displayed M. hominis DNA at a concentration of 108 GE/ml (that corresponded to total concentration of DNA of the bacteria that were present in the biomaterial). Other microorganisms were not found in one case; their concentration was 100 and more times lower than that of M. hominis in the other case. Conclusion. The most probable etiological role of M. hominis was established in two clinical cases of PID. The possible role of M. hominis in the development of PID should be taken into account when elaborating the tactics of examination and treatment for patients with this condition.</p></abstract><trans-abstract xml:lang="ru"><p>Актуальность. Несмотря на то, что M. hominis принято относить к условно-патогенным микроорганизмам, описано множество клинических случаев с участием M. hominis как единственного микроорганизма в развитии тяжелых воспалительных процессов в легких, межпозвоночных дисках, почках, печени, сердце и головном мозге. Роль M. hominis в развитии воспалительных заболеваний органов малого таза (ВЗОМТ) остается неизученной. Описание клинических наблюдений. Представлены данные по двум пациенткам, поступившим в стационар для лечения тубоовариального абсцесса и пиосальпинкса. Пациенткам проведено комплексное обследование, выполнена лапароскопия, в ходе которой получен интраоперационный материал, исследованный с применением полимеразной цепной реакции для обнаружения ДНК широкого спектра микроорганизмов. В материале, полученном от двух пациенток с ВЗОМТ, обнаружена ДНК M. hominis в концентрации 108 ГЭ/мл (соответствует суммарной концентрации ДНК бактерий, присутствующих в биоматериале). Других микрооорганизмов в одном случае обнаружено не было, во втором случае их концентрация была ниже таковой M. hominis в 100 и более раз. Заключение. В двух клинических наблюдениях ВЗОМТ было установлено, что наиболее вероятная этиологическая роль принадлежит M. hominis. Возможная роль M. hominis в развитии ВЗОМТ должна учитываться при построении тактики обследования и лечения пациенток с ВЗОМТ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Mycoplasma hominis</kwd><kwd>tubo-ovarian abscess</kwd><kwd>pyosalpinx</kwd><kwd>Mycoplasma hominis</kwd><kwd>pelvic inflammatory diseases</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>тубоовариальный абсцесс</kwd><kwd>пиосальпинкс</kwd><kwd>воспалительные заболевания органов малого таза (ВЗОМТ)</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Centers for Disease Control and Prevention (CDC) STD Treatment Guidelines. MMWR Recomm. Rep. 2010; 59: 45.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Ross J., Judlin P., Jensen J. 2012 European guideline for the management of pelvic inflammatory disease. Int. J. STD AIDS. 2014; 25: 1-7.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Yang T.K., Chung C.J., Chung S.D., Muo C.H., Chang C.H., Huang C.Y. Risk of endometrial cancer in women with pelvic inflammatory disease: a nationwide population-based retrospective cohort study. Medicine(Baltimore). 2015; 94(34): e1278. doi: 10.1097/MD.0000000000001278.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Ness R.B., Kip K.E., Hillier S.L., Soper D.E., Stamm C.A., Sweet R.L. A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. Am. J. Epidemiol. 2005; 162(6): 585-90.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Haggerty C.L., Totten P.A., Tang G., Astete S.G., Ferris M.J., Norori J. et al. Identification of novel microbes associated with pelvic inflammatory disease and infertility. Sex. Transm. Infect. 2016; 92(6): 441-6. doi: 10.1136/ sextrans-2015-052285.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Hussain S.T., Gordon S.M., Tan C.D., Smedira N.G. Mycoplasma hominis prosthetic valve endocarditis: the value of molecular sequencing in cardiac surgery. J. Thorac. Cardiovasc. Surg. 2013; 146(1): e7-9. doi: 10.1016/j. jtcvs.2013.03.039.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Vogel U., Lüneberg E., Kuse E.R., Neulinger A.L., Frosch M. Extragenital Mycoplasma hominis infection in two liver transplant recipients. Clin. Infect. Dis. 1997; 24(3): 512-3.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Camara B., Mouzin M., Ribes D., Esposito L., Guitard J., Game X. et al. Perihepatitis and perinephric abscess due to Mycoplasma hominis in a kidney transplant patient. Exp. Clin. Transplant. 2007; 5(2): 708-9.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Flouzat-Lachaniette C.H., Guidon J., Allain J., Poignard A. An uncommon case of Mycoplasma hominis infection after total disc replacement. Eur. Spine J. 2013; 22(Suppl. 3): S394-8. doi: 10.1007/s00586-012-2511-9.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Hos N.J., Bauer C., Liebig T., Plum G., Seifert H., Hampl J. Autoinfection as a cause of postpartum subdural empyema due toMycoplasma hominis. Infection. 2015; 43(2): 241-4. doi: 10.1007/s15010-014-0713-2.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Randall C.L., Baetz R.W., Hall D.W., Birtch P.K. The effect of treatment on the incidence of abortion. N. Y. State J. Med. 1950; 50(21): 2525-30.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Melen B., Gotthardson A. Complement fixation with human pleuropneumonia-like organisms. Acta Pathol. Microbiol. Scand. 1955; 37(2): 196-200.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Mardh P.A., Weström L. Tubal and cervical cultures in acute salpingitis with special reference to Mycoplasma hominis and T-strain mycoplasmas. Br. J. Vener. Dis. 1970; 46(3): 179-86.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Mardh P.A., Weström L. Antibodies to Mycoplasma hominis in patients with genital infections and in healthy controls. Br. J. Vener. Dis. 1970; 46(5): 390-7.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Möller B.R., Taylor-Robinson D., Furr P.M., Freundt E.A. Acute upper genital-tract disease in female monkeys provoked experimentally by Mycoplasma genitalium. Br. J. Exp. Pathol. 1985; 66(4): 417-26.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Румянцева Т.А., Савочкина Ю.А., Долгова Т.И., Зайцева С.В., Кахерская М.А., Кудрявцева Л.В., Гущин А.Е. Диагностика вульвовагинального кандидоза: сопоставление информативности клинических данных и результатов лабораторных исследований. Акушерство и гинекология. 2015; 3: 55-61.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Румянцева Т.А., Варламова А.В., Гущин А.Е., Безруков В.М. Сравнение тестов для количественной оценки Ureaplasma parvum, Ureaplasma urealyticum, Mycoplasma hominis: «Mycoplasma Duo», «Уреаплазма Микротест», «Микоплазма Микротест» и «Флороценоз-Микоплазмы». Клиническая лабораторная диагностика. 2014; 8: 52-7</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Rumyantseva T., Golparian D., Nilsson C.S., Johansson E., Falk M., Fredlund H. et al. Evaluation of the new AmpliSens multiplex real-time PCR assay for simultaneous detection of Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma genitalium, and Trichomonas vaginalis. APMIS. 2015; 123(10): 879-86 doi: 10.1111/apm.12430.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Rumyantseva T., Shipitsyna E., Guschin A., Unemo M. Evaluation and subsequent optimizations of the quantitative AmpliSens Florocenosis/Bacterial vaginosis-FRT multiplex real-time PCR assay for diagnosis of bacterial vaginosis. APMIS. 2016; Oct 7. doi: 10.1111/apm.12608.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Rumyantseva T.A., Bellen G., Savochkina Y.A., Guschin A.E., Donders G.G. Diagnosis of aerobic vaginitis by quantitative real-time PCR. Arch. Gynecol. Obstet. 2016; 294(1): 109-14.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Sonnex C. Toll-like receptors and genital tract infection. Int. J. STD AIDS. 2010; 21(3): 153-7.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Peltier M.R., Freeman A.J., Mu H.H., Cole B.C. Characterization and partial purification of a macrophage-stimulating factor from Mycoplasma hominis. Am. J. Reprod. Immunol. 2005; 54(6): 342-51.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Hasebe A., Mu H.H., Cole B.C. A potential pathogenic factor from Mycoplasma hominis is a TLR2-dependent, macrophage-activating, P50-related adhesin. Am. J. Reprod. Immunol. 2014; 72(3): 285-95. doi: 10.1111/ aji.12279.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Menard J.P., Fenollar F., Henry M., Bretelle F., Raoult D. Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. Clin. Infect. Dis. 2008; 47(1): 33-43. doi: 10.1086/588661.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Cox C., Watt A.P., McKenna J.P., Coyle P.V. Mycoplasma hominis and Gardnerella vaginalis display a significant synergistic relationship in bacterial vaginosis. Eur. J. Clin. Microbiol. Infect. Dis. 2016; 35(3): 481-7. doi: 10.1007/ s10096-015-2564-x.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Hedges S.R., Barrientes F., Desmond R.A., Schwebke J.R. Local and systemic cytokine levels in relation to changes in vaginal flora. J. Infect. Dis. 2006; 193(4): 556-62.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Allen-Daniels M.J., Serrano M.G., Pflugner L.P., Fettweis J.M., Prestosa M.A., Koparde V.N. Identification of a gene in Mycoplasma hominis associated with preterm birth and microbial burden in intra-amniotic infection Am. J. Obstet. Gynecol. 2015; 212(6): 779. e1-779. e13.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Taylor B.D., Darville T., Ferrell R.E., Ness R.B., Haggerty C.L. Racial variation in toll-like receptor variants among women with pelvic inflammatory disease. J. Infect. Dis. 2013; 207(6): 940-6. doi: 10.1093/infdis/jis922.</mixed-citation></ref></ref-list></back></article>
